Oscar Health (NYSE:OSCR) Shares Down 9.7% – Here’s Why

Shares of Oscar Health, Inc. (NYSE:OSCR) traded down 9.7% during mid-day trading on Thursday . The stock traded as low as $26.26 and last traded at $27.1790. 3,839,218 shares were traded during trading, a decline of 47% from the average daily volume of 7,237,161 shares. The stock had previously closed at $30.11.

Trending Headlines about Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Substantial earnings and revenue beat: Oscar reported quarterly EPS of $1.10, versus the $0.40–$0.43 analyst consensus, compared with a $0.89 loss in the year-ago quarter. Revenue rose 70.4% to $4.88 billion, exceeding estimates of approximately $4.73 billion. Oscar Health Inc. Q2 Earnings Beat Estimates
• Positive Sentiment: Profitability improved sharply: The insurer generated approximately $361 million of second-quarter profit and more than $1 billion in net income during the first half, helped by membership growth and easing medical costs. Oscar Health Reports Another Big Profit
• Positive Sentiment: Full-year outlook was raised: Oscar increased its 2026 revenue forecast to $18.7 billion–$19.0 billion, above the roughly $18.6 billion consensus estimate, and indicated $500 million–$700 million in earnings from operations with an 81.5%–82.5% medical-loss-ratio target. Oscar Health Signals 2026 Earnings Outlook
• Neutral Sentiment: The results reinforce Oscar’s improving profit-turnaround story, with technology and operational execution remaining important to managing a changing customer base. Oscar Health 2026 Profit Turnaround
• Negative Sentiment: Churn outlook pressured the shares: Management’s forecast for elevated member churn raised concerns about retention, future enrollment growth and whether the unusually strong earnings can be sustained. That concern reportedly outweighed the quarterly beat and guidance increase. Oscar Health Falls as Churn Forecast Overshadows Q2 Beat

Analyst Upgrades and Downgrades

Several research firms recently commented on OSCR. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Weiss Ratings raised Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Wells Fargo & Company set a $20.00 target price on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. UBS Group upped their price target on Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research report on Friday. Finally, Robert W. Baird set a $27.00 price target on Oscar Health in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $24.00.

Oscar Health Trading Up 5.2%

The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $8.42 billion, a P/E ratio of 19.95, a PEG ratio of 1.35 and a beta of 2.36. The firm’s fifty day moving average price is $28.93 and its two-hundred day moving average price is $20.37.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 44.96% and a net margin of 3.60%.The company had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same quarter last year, the company earned ($0.89) earnings per share. The firm’s quarterly revenue was up 70.4% on a year-over-year basis. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.63 EPS for the current year.

Insider Transactions at Oscar Health

In other news, CFO Richard Scott Blackley sold 31,683 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $695,125.02. Following the completion of the transaction, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at approximately $23,584,995.38. The trade was a 2.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,859 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at approximately $4,785,026.24. This trade represents a 4.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 3,662,466 shares of company stock worth $105,145,815. 22.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp increased its holdings in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio bought a new stake in shares of Oscar Health during the 1st quarter worth $30,000. Fifth Third Bancorp lifted its holdings in shares of Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the last quarter. CoreCap Advisors LLC grew its position in Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock worth $34,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Quarry LP grew its position in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.